Remnant cholesterol, vascular risk, and prevention of atherosclerosis DOI
Xavier Pintó, Marta Fanlo‐Maresma, Virginia Esteve-Luque

et al.

Clínica e Investigación en Arteriosclerosis (English Edition), Journal Year: 2023, Volume and Issue: 35(4), P. 206 - 217

Published: July 1, 2023

Language: Английский

Effect of Post-acute Kidney Injury Use of Renin-Angiotensin Inhibitors on Long-term Mortality and Major Adverse Kidney Events: A 5-year Retrospective Observational Cohort Study DOI Creative Commons
Byorn W.L. Tan,

Bryce W. Q. Tan,

K Akalya

et al.

Kidney Medicine, Journal Year: 2025, Volume and Issue: unknown, P. 100996 - 100996

Published: March 1, 2025

Language: Английский

Citations

0

Predicción del riesgo cardiovascular a 10 años en los trabajadores del Servicio Navarro de Salud-Osasunbidea. Período 2019-2023 DOI
José Nobrega-De-Franca, Vega García López,

S. Álvarez Erviti

et al.

Atención Primaria, Journal Year: 2025, Volume and Issue: 57(10), P. 103260 - 103260

Published: March 26, 2025

Language: Английский

Citations

0

A prospective, multicenter, randomized controlled trial evaluating anticoagulation alone vs anticoagulation plus computer assisted vacuum thrombectomy for the treatment of intermediate-high-risk acute pulmonary embolism: Rationale and design of the STORM-PE study DOI Creative Commons
Rachel Rosovsky, Stavros Konstantinides, John M. Moriarty

et al.

American Heart Journal, Journal Year: 2025, Volume and Issue: unknown

Published: March 1, 2025

Therapeutic anticoagulation (AC) is standard care for pulmonary embolism (PE). Endovascular therapy with mechanical thrombectomy (MT) commonly performed PE and well-studied in single-arm trials. The efficacy benefit of MT over AC alone a randomized fashion remains unstudied. STORM-PE (ClinicalTrials.gov Identifier: NCT05684796) post-market, international, open-label trial conducted partnership Pulmonary Embolism Response Team ConsortiumTM. Up to 100 patients confirmed acute intermediate-high-risk demonstrated by right ventricular (RV) dysfunction right-to-left (RV/LV) ratio ≥1.0 elevated cardiac biomarkers will be 1:1 receive or plus Computer Assisted Vacuum Thrombectomy (CAVT) the Indigo Aspiration System (Penumbra Inc.). primary outcome mean change RV/LV at 48 hours, assessed computed tomographic angiography (CTPA) adjudicated blinded, independent imaging Core Lab. Additional endpoints are composite major adverse events, functional outcomes (6-minute walk test, New York Heart Association classification, post-venous thromboembolism status scale, modified Medical Research Council Dyspnea Scale, Borg Scale), quality life (Pulmonary Quality Life Questionnaire EQ-5D-5L), mortality, symptomatic recurrence through 90 days. A Clinical Events Committee adjudicate events causality attribution an Data Safety Monitoring Board oversee study. funded Penumbra Inc. help inform future guidelines standards related frontline treatment using CAVT PE. STORM-PE, NCT05684796, registered https://clinicaltrials.gov/study/NCT05684796.

Language: Английский

Citations

0

Use of finerenone in patients with chronic kidney disease at high risk of heart failure DOI

J Hakim,

Yehuda Handelsman,

Trina Banerjee

et al.

Metabolism, Journal Year: 2025, Volume and Issue: unknown, P. 156297 - 156297

Published: May 1, 2025

Language: Английский

Citations

0

Cardiac rehabilitation and acute aortic dissection: understanding and addressing the evidence GAP a systematic review DOI Creative Commons
Andreina Carbone, Nicola Lamberti, Roberto Manfredini

et al.

Current Problems in Cardiology, Journal Year: 2024, Volume and Issue: 49(3), P. 102348 - 102348

Published: Jan. 21, 2024

Despite guideline recommendations, strategies for implementing cardiac rehabilitation (CR) in patients with acute aortic dissection (AAD) are not well established little evidence to risk stratify prudent and effective guidelines the many required variables. We conducted a systematic review of studies (2004-2023) reporting CR following type A (TA) B (TB) AAD. Our is limited open surgical repair TA medical treatment TB. total 5 were included (4 TA-AAD 1 TB-AAD) qualitative analysis. In general, observational data 311 who had an overall favorable effect AAD consisting modestly improved exercise capacity work load during cycle cardiopulmonary test (TB-AAD), quality life (QoL). No adverse events reported symptom pre-CR treadmill or VO2 max CR. Given potential this high population without adequate important variables such as safe time from post-op CR, intensity training, duration frequency sessions followup it moderate sized designed trial patients' surgery medically treated TB-AAD standardized based therapy physical discharge randomized versus usual care. PROSPERO registry ID: CRD42023392896.

Language: Английский

Citations

2

The burden of cardiovascular disease and related risk factors in Greece: the ATTICA epidemiological study (2002–2022) DOI Creative Commons
Demosthenes B. Panagiotakos, Evangelia G. Sigala, Evangelia Damigou

et al.

Hellenic Journal of Cardiology, Journal Year: 2024, Volume and Issue: unknown

Published: May 1, 2024

The aim of this study was to present the burden cardiovascular disease (CVD) and its related risk factors based on a 20-year observation period (2002-2022).

Language: Английский

Citations

2

Colesterol remanente, riesgo vascular y prevención de la arteriosclerosis DOI
Xavier Pintó, Marta Fanlo‐Maresma, Virginia Esteve-Luque

et al.

Clínica e Investigación en Arteriosclerosis, Journal Year: 2023, Volume and Issue: 35(4), P. 206 - 217

Published: March 6, 2023

Language: Английский

Citations

5

Documento de consenso para la determinación e informe del perfil lipídico en laboratorios clínicos españoles DOI Creative Commons

Teresa Arrobas Velilla,

Carlos Guijarro,

Raquel Campuzano Ruiz

et al.

Clínica e Investigación en Arteriosclerosis, Journal Year: 2023, Volume and Issue: 35(2), P. 91 - 100

Published: March 1, 2023

Cardiovascular diseases (CVD) continue to be the main cause of death in our country. Adequate control lipid metabolism disorders is a key challenge cardiovascular prevention that far from being achieved real clinical practice. There great heterogeneity reports Spanish laboratories, which may contribute its poor control. For this reason, working group scientific societies involved care patients at vascular risk, has prepared document with consensus proposal on determination basic profile prevention, recommendations for realization and unification criteria incorporate goals appropriate risk laboratory reports.

Language: Английский

Citations

4

The effect of web-based education delivered as part of cardiac rehabilitation on healthy lifestyle behaviors, and quality of life in patients with coronary artery disease in Turkey: A randomised controlled trial DOI

Semiha Alkan Kayhan,

Nesrın Nural

Patient Education and Counseling, Journal Year: 2023, Volume and Issue: 119, P. 108082 - 108082

Published: Nov. 18, 2023

Language: Английский

Citations

4

Clinical profile of severe hypercholesterolemia in 156,000 adults in primary care DOI
Teresa Gijón‐Conde,

Carolina Ferré Sánchez,

Isabel Ibáñez Delgado

et al.

Clínica e Investigación en Arteriosclerosis (English Edition), Journal Year: 2024, Volume and Issue: 36(1), P. 1 - 11

Published: Jan. 1, 2024

Citations

1